Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 18 jan 2019 - 22:00
  • Statutory name argenx SE
  • Title argenx announces closing of exclusive global collaboration and license agreement for cusatuzumab (ARGX-110) with Janssen

Related downloads

201901200000000001_argenx announces closing of exclusive global collaboration and license agreement for cusatuzumab.pdf

Date last update: 24 May 2019

Share information

Share on: Share this